216.00
-1.00 (-0.46%)
-1.00 (-0.46%)
Upgrade to Real-Time
Afterhours (Closed)
Low
54.21
High
227.63
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.00 | -0.46% | 216.00 | 00:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 211.91 | 211.80 | 218.90 | 218.85 | 217.00 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 206.58 | 249.98 | 43.40 | 3 | 4 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 76,048 | 5,576,026 | $ 215.09 | $ 1,199,359,811 | 9,784,451 | 54.21 - 227.63 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:53 | 5 | $ 216.00 | USD |
Moderna Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 86.73B | 401.53M | 293.40M | $ 803.40M | $ 175.86M | -1.95 | 175.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -4.69M | 5.90% |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 197.50 | 227.63 | 197.33 | 215.12 | 12,339,123 | 18.50 | 9.37% |
| 1 Month | 150.85 | 227.63 | 150.40 | 191.32 | 8,159,298 | 65.15 | 43.19% |
| 3 Months | 143.06 | 227.63 | 117.3411 | 167.13 | 9,480,095 | 72.94 | 50.99% |
| 6 Months | 159.78 | 227.63 | 102.66 | 149.10 | 12,908,516 | 56.22 | 35.19% |
| 1 Year | 62.95 | 227.63 | 54.21 | 113.82 | 15,765,072 | 153.05 | 243.13% |
| 3 Years | 22.00 | 227.63 | 11.54 | 86.84 | 9,936,339 | 194.00 | 881.82% |
| 5 Years | 22.00 | 227.63 | 11.54 | 86.84 | 9,936,339 | 194.00 | 881.82% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
